PEG & ADCs
- Global Sales of Antibody-drug Conjugates (ADCs) in 2024
- Global Sales of ADCs in 2023 – UP to 10 Billion
- Three ADCs Expected To Be Approved In 2024-2025
- What Are ADC Payloads?
- Antibody-drug Conjugates (ADCs) - Approvals by FDA/EMA/NMPA/PMDA
- FDA Approves Datroway (Datopotamab Deruxtecan) in HR+/HER2– Breast Cancer
- FDA Approved Antibody-Drug Conjugates (ADCs) By 2025
- Review: Novel Payloads for Antibody-drug conjugates (ADCs)
- Antibody–Drug Conjugate Payloads: MMAE & MMAF
- Radionuclide Drug Conjugates (RDCs): Current Status